Acutus Medical touts 12-month AcQMap-guided AF ablation trial data

Acutus Medical today released 12-month data from the Uncover-AF trial of its AcQMap cardiac imaging and mapping system exploring its use in persistent atrial fibrillation ablation procedures. Results from the trial were presented at the 24th Annual AF Symposium in Boston, the Carlsbad, Calif.-based company said. Acutus Medical’s AcQMap system is designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D images of the heart chamber using ultrasound. “We have mapped arrhythmias with the same technology for decades without asking if there’s a better way to locate ablation targets and deliver a more precise, patient-specific therapy. The results of the Uncover-AF trial demonstrate that with better imaging, we can perform patient-centric ablations with great success, while dramatically improving patient quality of life. This advanced cardiac imaging system paints a complete, high-definition picture in real time and is an important step in advancing the standard of care for AF ablation procedures,” principal investigator Dr. Atul Verma said in a prepared statement. Investigators in the 127-patient trial explored the use of the AcQMap system in combination with a variety of on-market ablation tech at 13 sites across Europe and Canada, Acutus said. Results from the trial indicated a 72.5% single-procedure freedom from AF at 1 year, while post-ablation monitoring indicated that 89.6% o...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiovascular Clinical Trials Acutus Medical Source Type: news